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and Genetics Laboratory rTG-DJ, Norsk Hydro'~; Institute for Cancer R esearch. Norwegian Radium Hospital , 
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Human skin collagenase was quantitated by radioimmunoassay in 40 patients with 
various forms of epidermolysis bullosa to compare levels of the enzyme in blistered and 
clinically unaffected skin. Immunoreactive human skin collagenase was significantly ele-
vated in the blistered skin of patients with both recessive and dominant forms of dystrophic 
epidermolysis bullosa (DEB). In addition, patients with generalized recessive DEB mani-
fested a 4-fold increase in collagenase protein in normal-appearing skin, and patients with 
localized recessive DEB or epidermolysis bullosa letalis showed a 3- to 3.5-fold elevation in 
the enzyme. However, patients with dominantly inherited DEB failed to display a statisti-
cally significant increase in immunoreactive collagenase in nonblistered skin. Although it 
cannot be definitely stated whether the elevated collagenase content in the blistered skin 
represents a primary or secondary event, such as part of a wound healing response, the 
demonstration of markedly increased levels of collagenase in normal-appearing skin could, 
in part, provide an explanatio11 at the molecular level for the formation of blisters in this 
disease. 
Epidermolysis bullosa (EB) is the term applied 
to a group of related genetic diseases whose pri-
mary common feature is the formation of blisters 
following trauma to the skin. Both genetic and 
epidemiologic studies indicate heterogeneity in 
this disease which may result from aJ!elic muta-
tions of varying severity 11). This complex situa-
tion is manifested in the existence of both domi-
nant and recessive forms of the disease, which 
vary in the severity of their clinical manifestations 
{1-3]. 
Although the etiology of this group of disorders 
is unknown, a possible molecular mechanism has 
been proposed in the recessive form of dystrophic 
epidermolysis bullosa (DEB) from studies which 
have shown that skin obtained from friction blis-
ters produced elevated levels of collagenase in or-
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gan culture L4]. This finding suggested that colla-
genase could participate in blister formation. In-
creased activity of this enzyme would be consistent 
with the electron microscopic findings of collagen 
degeneration and the phagocytosis of collagen fi-
brils by dermal macrophages in DEB (5]. 
Despite the apparent presence of increased col-
lagenase activity in blistered EB skin, it has re-
mained unclear whether the in vitro observations 
reflect the in vivo pathophysiology of the disease 
or represent a nonspecific or secondary (wound 
healing) response limited to blistered skin l6,7l. If 
the genetic abnormality were to result in a funda-
mental biochemical change characterized by an 
excess of collagenase, this should be reflected in 
unaffected skin as well. 
A major difficulty in determining the signifi-
cance of collagenase in the in vivo degradation of 
collagen has been the inability to detect the active 
enzyme readily in vivo [6]. Thus, to evaluate fur-
ther the in vivo role of collagenase we have devel-
oped a specific radioimmunoassay for quantitating 
collagenase in biologic material 18] and have uti-
lized this technique to examine both blistered and 
clinically uninvolved skin in DEB. 
MATERIALS AND METHODS 
Patient Sources 
A total of 40 patients with EB from the United States 
and Norway were examined in this study as well as 23 
healthy volunteers who served as controls. The Norwe-
gian patients have been studied in detail both clinically 
11 9 
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and genetically 11 ,21. For the purpose of comparison, 
patients were divided inlo four groups based on the 
inheritance patterns and the clinical criteria shown in 
Table I. In addition, in order for patients to be com-
pared conveniently, the coding used by other investiga-
tors in reporting on different aspects of this disease 
[1,2,9-14] has been included in Table I. Random biop-
sies taken from clinically unaffected skin of EB patients 
were histopathologically normal by light microscopy. 
Electron microscopic examinations, when available, 
were used to confirm the clinical groupings. 
consent. Skin biopsies were obtained from fresh blisters 
(less than 48 hr old) in 21 patients and from clinically 
uninvolved skin in 34 patients. Although an effort was 
made t.o obtain skin biopsies from both affected and 
unaffected skin in all EB patients, this was not always 
feasible. Since t.he main objective of the study was to 
assess collagenase levels in non blistered skin in EB, if a 
choice was necessary, a biopsy was preferentially ob-
tained from uninvolved skin. 
Preparation of Tissue Extracts 
For determination of skin collagenase levels, two 3-
mm-diameter punch biopsies were obtained under local 
anesthesia with 1% lidocaine after obtaining informed 
Immediately after the biopsies were obtained, speci-
mens were blotted on filter paper and their wet weights 














Clinical and laboratory findings 
13 Onset at birth or early infancy 
Widespread, severe blistering, which heals with muti-
lating scars and milia 
Nail dystrophy 
Digital fusion common 
Oral blistering common with dysplastic teeth 
Some patients with "inverse" distribution 
Anemia common 
Blister below basal lamina on electron microscopy 
(dermolytic) 
12 Onset at birth or early infancy; later in a few 
Distribution primarily on hands. feet , elbows, knees 
Blisters heal with scarring and milia formation 
Nail dystrophy 
Mouth involvement less prominent and severe than in 
generalized recessive DEB 
Blister below basal lamina on electron microscopy 
<dermolyticl 
5 Onset at birth 
Widespread blistering, often sparing distal extremi-
ties 
Large granulating ulcers 
Heal without primary scar formation unless secondar-
ily infected 
Variable nail dystrophy 
Severe oral involvement with dystrophy of teeth 
Severe anemia 
Junctional (intermembranous space) blister on elec-
tron microscopy 
10 Onset in infancy or later 
Blister mainly on hands, feet, elbows, knees; may be 
widespread 
Healing with atrophic scars and milia formation 
Nail dystrophy 
Mouth involvement mild 
Pasini variant shows albopapuloid lesions 
Blister below basal lamina on electron microscopy 
(dermolytic) 
Coding of previously 
reported cases 
EB 2-4, EB 10-1 
EB 11-1. EB 19-1 
EB 24-1, EB 24-38 
EB 71-1, EB 75-1 
EB 10-98, EB 12-1 
EB 17-1 , EB 17-2, 
EB 27-1, EB 33-1, 
EB 40-2, EB 57-100, 
EB 67-1, EB 77-1 
Case #4 and #5 
Case #1 and #2 
EB 26-1, EB 78-1 
EB 16-13, EB 16-14 
EB 16-31. EB 16-91 
EB 28-1 
" Nine of 13 patients had dermolytic blistering confirmed by electron microscopy. 
1
' Seven of 12 patients had dermolytic blistering confirmed by e lectron microscopy. 
' All 5 patients had junctional blistering on electron microscopy. 
'
1 Three of 10 patients had dermolytic blistering confirmed by electron microscopy. 
Refer-
ences 
1, 2, 14 




1' 2, 12 
1, 2, 13 
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specimens was 7.4o/f'. One specimen was used for deter-
mination of dry weight after drying for 48 hr at 13o•c in 
an Abderhalden pistol. The second specimen was pro-
cessed immediately as described previously 18]. The 
tissue was minced finely with a razor blade and homog-
enized in an an-glass homogenizer at o· c using t hree 
separate 1.0-ml a liquots of 0.05 M Tris-HCl CpH 7.5) 
containing 0.15 M NaCI fTris-NaCl buffer). Following 
the third homogenization. the suspended ti ssue was 
subjected to ultrasonication for 30 sec at an intensity of 
30 using a Sonic Dismembrator equipped with a micro-
probe (Artex Systems). The supernatant fractions from 
these three sequential extractions were pooled, di-
alyzed, and lyophilized. After reconstituting the lyophi-
lized extracts in Tris-NaCJ buffer, serial doubling dilu-
tions were prepared for use in the radioimmunoassay 
with 1% bovine serum albumin (BSA) in Tris-NaCl 
buffer. In addition, an aliquot of the und iluted material 
was examined for collagenase activity by incubation 
with 14C-labe1ed collagen fibrils (vide infra). 
Radioimmunoassay for Human Skin Coflagenase 
The radioimmunoassay for human skin collagenase 
(HSC) was performed using a slight modification of the 
double antibody technique detailed previously 181. HSC 
was prepared from tissue culture medium as described 
previously [8] and iodination of the purified enzyme 
was carried out by the lactoperoxidase method l15j. 
Functionally monospecific antiserum to HSC was pre-
pared in rabbits (]6) and the gamma globulin fraction 
was obtained by precipitation with 33'k saturated am-
monium sulfate at o·c and pH 7.0. The precipitate was 
dissolved in Tris-NaCl buffer and adjusted to the initial 
volume of serum. Goat antirabbit lgG was obtained 
commercia lly (Gateway Irnmunochemicalsl and sub-
jected to an identical ammonium sulfate fractionation 
prior to use. Standard inhibition curves were performed 
in duplicate using disposable plastic microfuge tubes 
(Beckman Instruments) which contained a 1:6000 dilu· 
tion of functionally monospecific anti-HSC gamma 
globulin, l '"''l ]HSC (approximately 10.000 cpm/t.ube). 
and 0-100 ng purified, unlabeled HSC in a total volume 
of 300 1.d. After incubation for 24 hr at 4°C, goat anti-
rabbit lgG was added in excess. The resulting precipi-
tates were isolated after 48 hr at 4•c. washed with 0.1 ~ 
buffered BSA. and counted in a single channel auto-
matic gamma scintillation spectrometer <Nuclear Chi-
cago). Unknowns, consisting of crude tissue extracts. 
were assayed for collagenase content in identical fash-
ion us ing 100-,~.d aliquots of serial doubling dilutions of 
the extracts. Controls without antiserum or in which 
nonimmune rabbit gamma globulin was substituted for 
anti-HSC were routinely included. Recovery of known 
quantities of purified HSC in this radioimmunoassay 
exceeds 95% 18]. 
Other Assays 
Collagenase activity was measured by the release of 
soluble I'4 C]glycine-labeled peptides from native, re-
constituted collagen fibrils , containing 4000 cpm per 
substrate gel Ll71 after incubation with 100 J.Li of active 
HSC obtajned from organ culture as a control or undi-
luted t issue extract for 18 hr at 37•c. In no case was 
significiant enzyme activity detected in the extracts by 
th is method. A mean value of0.2% lysis (range 0-1.5%) 
of the collagen gel above a buffer blank was obtained 
from the extracts examined, while the mean value for a 
10-J.Lg trypsin control under the same conditions was 
~ .6% lysis above the blank. 
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Protein was determined 118] using crystalline BSA 
as a standard. 
Statistical analysis was performed using both Stu-
dent's t -test and the multivariate analysis of variance 
119]. Each collagenase determination was quantitated 
in terms of two parameters, wet and dry weight. Since 
the collagenase contents based on wet and dry weight 
were significanlly correlated (r = 0.896, p < 0.01), the 
data have been presented as immunoreactive HSC 
(iHSC) per dry weight only. 
RESULTS 
The close similarity of iHSC from EB skin ex-
tracts to enzymatically active collagenase ob-
tained from cultur e medium of normal skin ex-
plants is seen in the standard inhibition cw-ve of 
the radioimmunoassay (Fig. 1). It is apparent that 
the slopes of the curves obtained using serial dou-
bling dilutions of representative crude tissue ex-
tracts from patients of each of the four groups-
dominant DEB, recessive EB letalis, localized re-
cessive DEB, and generalized recessive DEB- are 
parallel with the standard cw-ve of the purified , 
active enzyme. This fmding indicates that colla-
genases from in vitro and in vivo sources are anti-
genically closely related and that immunologic 
techniques can be used to quantitate levels of t he 
enzyme protein (iHSC) in these patients. 
In initial studies iHSC was quantitated in the 
involved (blistered) skin of 21 EB patients and 
compared to the content of immunoreactive en-
EXTRACT DILUTION 























HUMAN SKIN COLLAGENASE (ng /tube) 
FIG. 1. Standard immunoassay curve for human 
skin collagenase. Aliquots of 100 J.Ll of either pw·ified 
HSC containing 0-100 ng protein or representative 
crude tissue extracts from each of the EB groups were 
reacted in the radioimmunoassay as described under 
Materials and Methods. ln control tubes, to which an 
equivalent amount of nonimmune rabbit gamma g lobu-
lin was added, 3'1t of the counts was precipitated. R-
DEB (gen. ), generalized recessive DEB; R-DEB ([oc.J. 
localized recessive DEB; R-EBL. recessive EB Jetalis; 
D-DEB , dominant DEB. 
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zyme protein in the skin of 23 healthy control 
subjects. As shown in Table ll, blister formation 
was associated with significant increases in tissue 
levels ofiHSC. This was true for both the recessive 
and dominant forms of DEB, where the mean 
increases in iHSC based on tissue dry weight were 
approximately 4- and 8-fold, respectively (p < 
0.02). 
In further studies, to assess the immediate effect 
of trauma (friction-induced blisters) on iHSC con-
tent, biopsies were taken from 16 patients with 
recessive EB approximately 15 min after gently 
stroking the skin with a cotton swab. A mean 
increase in iHSC content of 1.8-fold was observed 
in 4 of7 generalized recessive DEB patients (range 
1.2- to 2.5-fold) when compared with a pretrauma 
biopsy. Similarly, 5 of 7 localized recessive DEB 
patients examined had a mean increase in iHSC of 
1. 7-fold (range, 1.2- to 2. 7-fold). Two recessive EB 
letalis patients failed to show a change in iHSC 
levels following induced blistering. 
Since it was possible that the increased colla-
genase content of blistered skin might be a second-
ary phenomenon related to the effect of trauma 
with subsequent wound healing, iHSC was also 
quantitated in clinically unaffected skin; i.e. , skin 
in which there was no evidence of either recent or 
remote blister formation. This approach was de-
signed to assess the possibility that a biochemical 
change characterized by excess collagenase might 
be expressed in uninvolved tissue. A total of 34 
patients from the four groups of EB were exam-
ined. Strikingly higher collagenase levels were 
present in patients with the recessively inherited 
form of generalized DEB (Fig. 2). The mean level 
of iHSC in clinically uninvolved skin in these 
patients was increased by approximately 4-fold 
when compared to normal controls (p < 0.001). 
Patients with localized recessive DEB and reces-
sive EB Jetalis also had mean tissue levels ofiHSC 
which were each approximately 3 to 3.5 times 
greater than normal (localized recessive DEB, p < 
0.001. and recessive EB letalis. p < 0.005l. It is 
noteworthy that in two of the recessive DEB pa-
tients, one generalized and the other localized, 
levels of the enzyme protein in uninvolved skin 
were 10 to 12 times greater than tissue levels of 
iHSC in the skin of healthy controls. Although 
each of the three recessive groups had signifi-
cantly elevated iHSC, there was no significant 
difference in iHSC content among any of the reces-
sive types. 
TABLE n. Collagenase content in blistered 









" Expressed as mean ± SE 
Immunoreactive HSC 
ng/mg dry weight• 
27.9 ± 2.4 
114.1 ± 31.6. 
235.9 = 84.9• 
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1><0001 P<0001 p<0005 o >O 1 
Control R-DEB R-DEB R-EBL D-DEB 
(gen l (loc) 
F'1c. 2. Quantiiation of collagenase in the clinically 
unaffected skin of patients with EB. HSC was mea-
sured by radioimmunoassay as described in Materials 
and Methods. R-DEB (gen .), generalized recessive 
DEB; R-DEB rloc.J, localized recessive DEB: R-EBL, 
recessive EB letalis; D-DEB , dominant DEB <Pasi ni 
variants only1. Dat.a are expressed as mean ± SE. The 
N refers to the number of patients sampled in each 
group. The range of values, expressed as ng/mg dry 
weight. for each group was as follows: Control. 4. 7-46.5: 
R-DEB {gen.). 33.8-314.0; R-DEB lloc.), 32.8-268.3: R-
EBL, 47.2- 146.5: D-DEB, 12.2-63.5. 
The mean iHSC content of uninvolved skin of 5 
patients with dominant DEB, as shown in Figure 
2, was s lightly increased. However, this value did 
not differ s ignificantly from that of the normal 
controls (p > 0.10}. 
The collagenase content of blistered skin was 
compru·ed with that of the adjacent, clinically un-
involved skin from the same patient in a total of 19 
patients from the four EB groups. Blistered skin in 
3 of the 8 generalized recessive DEB patients ex-
amined had concentrations of iHSC which were 
approximately 3.5 times greater than adjacent un-
involved skin. In the remaining generalized reces-
sive DEB patients there was no significant differ-
ence in the iHSC content of involved versus unin-
volved skin. ln 4 localized recessive DEB patients 
and 3 recessive EB letalis patients, the greatest 
increase in iHSC content observed in associa tion 
with blister formation was 1.6-fold. Thus, the re-
cessive groups manifested considerable heteroge-
neity when comparing blistered and uninvolved 
skin from the same patient. 
In each of 4 patients with dominant DEB, blis-
tered skin contained an increased tissue content of 
iHSC. Mean levels of the enzyme were approxi-
mately 2.5 times greater (range, 1.2 to 8.2 times) 
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than those of unaffected skin from the same pa-
tients. The dominant DEB patients, therefore, 
consistently showed a difference in iHSC content 
between blistered and uninvolved skin; however, 
since the number of patients where it was possible 
to do such a comparison was small, meaningful 
statistics could not be obtained. 
DISCUSSION 
Tissue levels of collagenase protein were signifi-
cantly elevated by radioimmunoassay in blistered 
skin of all groups of EB patients examined when 
compared to the skin from healthy controls, even 
though, as has been shown previously [6), colla-
genase activity could not be detected in crude ex-
tracts of DEB skin. Of major importance was the 
finding of a significantly increased concentration 
of the enzyme protein in clinically uninvolved skin 
in the recessive EB patients. However, in domi-
nant DEB, while the iHSC content of blistered 
skin was 2.5 times greater than that of uninvolved 
skin, levels of the enzyme in normal-appearing 
skin of the small number of patients available to 
us for study suggest that the iHSC content may 
not differ significantly from normal. Thus, despite 
several clinical similarities between dominant and 
recessive DEB, it appears that differences in path-
ogenesis exist, at least with respect to collagenase 
production or turnover. 
It is intriguing that in vitro tissue explants of 
DEB nonb!istered skin fail to express collagenase 
activity to the same extent iHSC is seen in vivo. 
The in vitro studies have shown that production of 
collagenase by clinically uninvolved skin is either 
moderately increased (2-foldl [4] or normal [7]. 
The precise explanation for the quantitative differ-
ences between collagenase activity in vitro and 
collagenase protein (iHSCl in vivo is unknown. 
However, it is possible that in vivo the enzyme is 
stored and secreted as a proenzyme [20-22) and, 
following trauma, requires conversion to the ac-
tive form. Since the radioimmunoassay does not 
distinguish between these two forms of the enzyme 
(unpublished observation), both active and inac-
tive enzyme proteins are quantitated. In this re-
gard release of a specific protease to activate the 
proenzyme [20,21) may be required for full expres-
sion of the collagenase which exists in the tissue in 
elevated concentrations. In addition , the presence 
of tissue inhibitors of collagenase may alter the 
expression of enzyme activity in vitro [22]. 
Although iHSC l evels in both blistered and non-
blistered skin of generalized recessive DEB pa-
tients were significantly elevated, it is of interest 
that 3 of 8 patients displayed higher levels of iHSC 
in blistered skin when compared to their own non-
blistered skin. In addition, by obtaining tissue 
samples shortly after inducing blister formation, 
an increase in iHSC could be detected in 9 of 14 
recessive DEB patients. These data correlate welt 
with the in vitro studies, which suggest that there 
is, indeed, greater collagenase production by ex-
plants of blistered skin in tissue culture [4, 7]. The 
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failure to find higher in vivo iHSC in blistered 
skin in every case may be in part related to the 
factors discussed above as well as to the considera-
ble patient heterogeneity, which has been well 
described on a clinical level [1] and may, thus, find 
biochemical expression in the quantity of collagen-
ase produced. 
The significant increase in iHSC in the clini-
cally unaffected skin of patients with recessively 
inherited DEB may provide the molecular mecha-
nism through which blister formation occurs given 
the proper stimulus. In support of this possibility 
is the fact that an increasing number of genetic 
diseases have been reported in which the abnor-
mality is manifested by excessive enzyme produc-
tion or activity rather than enzyme daficiency . 
The possible causes for this increase have been 
detailed by Becker et al [23) and include (a ) the 
presence of small molecular effectors which may 
alter the activity of a structurally normal en-
zyme; (b) a n alteration in the primary structure of 
the protein, resulting in a change in the catalytic 
properties of the enzyme or in a decreased rate of 
enzyme degradation; (c) a primary alteration in 
the regulation of synthesis of the enzyme; and (d) 
an increase in enzyme protein or activity second-
ary to deficiency of another enzyme or inhibitor 
molecule. 
Each of these possibilities must be considered in 
assessing the potential role of collagenase in DEB. 
At present it is not known whether the elevated 
iHSC is the result of either increased synthesis or 
decreased degradation or whether there is an al-
teration in the primary structure of this enzyme, 
such as in the Hektoen variant of glucose-6-phos-
phate dehydrogenase 124]. A biochemical defect is 
currently being sought in recessive DEB. How-
ever, in view of the considerable clinical heteroge-
neity among the recessive patients [1], it is un-
likely that the same enzyme defect will be the 
underlying problem in all recessive patients. It is 
possible that in some DEB patients an increase in 
collagenase may be secondary to a deficiency of 
another enzyme or inhibitor protein. 
It is also of interest in this group of genetic 
disorders that electron microscopic studies of DEB 
have shown an absence of anchoring fibrils in the 
sub-basal lamina area of the dermis [3,14,25]. 
Briggaman and Wheeler [25) have shown that in 
recessive DEB dermis there is an impairment in 
the formation of anchoring fibrils and postulate 
that this structural abnormality is linked to blis-
ter formation. Others, however, have suggested 
that a decrease or absence of anchoring fibrils can 
be seen both in recessive and dominant DEB. In 
addition. there is a great deal of variability in 
presence or absence of the fibrils when multiple 
biopsies are taken from the same patient [12-14]. 
It is tempting to speculate that the excess of colla· 
genase may be responsible for the absence of an-
choring fibrils. Studies are currently in progress to 
determine whether these structural components 
can serve as a substrate for the enzyme. 
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